One‐year safety, healing and amputation rates of Wagner 3‐4 diabetic foot ulcers treated with cryopreserved umbilical cord (TTAX01)

An open label, multicenter 16‐week trial of cryopreserved human umbilical cord (TTAX01) was previously undertaken in 32 subjects presenting with a Wagner grade 3 or 4 diabetic foot ulcer, with 16 (50%) of these having confirmed closure following a median of one product application (previous study)....

Descripción completa

Detalles Bibliográficos
Autores principales: Marston, William A., Lantis, John C., Wu, Stephanie C., Nouvong, Aksone, Clements, John Randolph, Lee, Tommy D., McCoy, Nicholas D., Slade, Herbert B., Tseng, Scheffer C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Research‐Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383512/
https://www.ncbi.nlm.nih.gov/pubmed/32386343
http://dx.doi.org/10.1111/wrr.12809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383512/
https://www.ncbi.nlm.nih.gov/pubmed/32386343
http://dx.doi.org/10.1111/wrr.12809

Ejemplares similares